Related Experiment Video

Updated: Jul 19, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in

Feng-Sheng Wang1, Jih-Yang Ko, Chun-Liang Lin

  • 1Department of Medical Research, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Graduate Institute of Clinical Medical Science, Chang Gung University College of Medicine, Kaohsiung, Taiwan. wangfs@ms33.hinet.net

Bone
|October 24, 2006
PubMed

Insights

This study shows that DKK1 antisense oligonucleotide treatment can prevent bone loss caused by estrogen deficiency in rats. This approach may offer a new strategy for treating osteoporosis by targeting Dickkopf-1 (DKK1) signaling.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Orthopedics

Background:

  • Dickkopf-1 (DKK1) is a key inhibitor of Wnt signaling, crucial for regulating bone metabolism.
  • Estrogen deficiency, common after menopause, leads to significant bone loss, increasing osteoporosis risk.
  • Understanding DKK1's role in estrogen loss-induced bone loss is vital for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the potential of modulating Dickkopf-1 (DKK1) expression using antisense oligonucleotides to counteract bone loss induced by estrogen deficiency.
  • To assess the impact of DKK1 antisense oligonucleotide treatment on bone mass, biomechanical properties, and cellular mechanisms of bone remodeling in an ovariectomized rat model.

Main Methods:

  • Ovariectomized and sham-operated rats were treated with DKK1 sense or antisense oligonucleotide or a vehicle control.
  • Bone mass, mineral content, and biomechanical strength of femurs and tibiae were evaluated.
  • Immunohistochemistry and ex vivo osteoclast formation assays were performed to analyze cellular changes and differentiation.

Main Results:

  • DKK1 antisense oligonucleotide treatment significantly preserved bone mass, mineral density, and biomechanical strength in ovariectomized rats.
  • Treatment reduced the differentiation of osteoclasts and increased osteoblast numbers, counteracting ovariectomy-induced bone loss.
  • DKK1 antisense oligonucleotide treatment decreased the expression of DKK1, RANKL, and increased OPG expression in bone tissue.

Conclusions:

  • Attenuation of Dickkopf-1 (DKK1) expression effectively alleviates estrogen deficiency-induced bone loss and improves bone biomechanical properties.
  • DKK1 antisense oligonucleotide treatment appears to work by suppressing RANKL expression and osteoclast differentiation, mitigating the effects of estrogen deficiency.
  • Targeting DKK1 signaling presents a promising therapeutic avenue for preventing and treating bone loss associated with estrogen deficiency.

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...